Transdermal hormone therapy: gels and patches

Area of Science:

• Gynecology
• Endocrinology
• Pharmacology

Background:

• Hormone therapy (HT) offers benefits for menopausal symptoms and osteoporosis prevention.
• Transdermal HT bypasses hepatic first-pass metabolism, unlike oral administration.
• Transdermal HT formulations include patches and gels, with gels developed to enhance patient compliance.

Purpose of the Study:

• To compare the efficacy of transdermal hormone therapy (patch vs. gel) with oral HT.
• To assess the effectiveness of different transdermal HT formulations in managing menopausal symptoms.
• To evaluate the impact of transdermal HT on bone mineral density.

Main Methods:

• Comparative analysis of transdermal (patch and gel) and oral hormone therapy.
• Assessment of climacteric symptom mitigation.
• Measurement of bone mineral density changes.

Main Results:

• Transdermal HT formulations (patch and gel) are equally effective in treating menopausal symptoms.
• Both transdermal routes demonstrate comparable efficacy to oral HT.
• Transdermal HT improves bone mineral density, similar to oral administration.

Conclusions:

• Transdermal hormone therapy, via patch or gel, is a viable alternative to oral HT for menopausal symptom management and osteoporosis prevention.
• Gel formulations may offer improved patient acceptability and compliance compared to patches.
• Transdermal HT provides comparable therapeutic benefits to oral HT without hepatic first-pass metabolism concerns.